Please remember that these discussion boards are a public forum, which means open to the public (i.e. non-CSN members) and the content can be found via internet search engines.
Members are strongly advised not to share personal identifiers such as real names, email address, telephone number, street address, etc. This information can be used to identify you and link you to the content you provide.
Other areas of CSN are restricted to members only and cannot be found by search engines.
Archives for November 2013
Acute biphenotypic leukemia
I am new here so I thought I would post a summary of my diagnosis. In 2008 I was diagnosed with acute biphenotypic leukemia at the age of 16. After going through chemotherapy I entered remission. At the age of 18 (2011) I relapsed and recieved a bone marrow transplant, and again went into remission. I decided to put off…
Test Shown to Reduce Early Cancer Deaths is Now Available to Patients
Huntington Beach, CA - SignatureCLL announced that the first laboratory test ever shown in a clinical trial to improve one year survival rates in cancer is now available to patients with chronic lymphocytic leukemia (also called CLL). The U.S. cancer physician who invented the test and the British scientist who used it to…
Hairy Cell Leukemia in 45 year old woman
A dear friend was diagnosed with HCL a week ago and started chemo (2 kinds) on Monday. She's having daily chemo. She'd been feeling bad for months and had a colonoscopy a few months ago because of feeling bloated all the time. Now she knows it was an enlarged spleen and not something else. She did have some pre cancerous…
Exciting new antibody targets all cancers, starting with AML; clinical trials at Oxford University a
The first drug to target a mutation common to all cancers goes to trial soon in the US and UK, Stanford and Oxford. Solid cancers in one trial, AML in the other. Trial headed by stem cell pioneer Irving Weissman of Stanford Univerity. Many peer reviewed journal papers are mentioned at below link for review. Good luck!…